SUMO wrestling with type 1 diabetes

Manyu Li, Dehuang Guo, Carlos M Isales, Decio L. Eizirik, Mark Atkinson, Jin-Xiong She, Cong Yi Wang

Research output: Contribution to journalReview article

68 Citations (Scopus)

Abstract

Post-translational modification of proteins by phosphorylation, methylation, acetylation, or ubiquitylation represent central mechanisms through which various biological processes are regulated. Reversible covalent modification (i.e., sumoylation) of proteins by the small ubiquitin-like modifier (SUMO) has also emerged as an important mechanism contributing to the dynamic regulation of protein function. Sumoylation has been linked to the pathogenesis of a variety of disorders including Alzheimer's disease (AD), Huntington's disease (HD), and type 1 diabetes (T1D). Advances in our understanding of the role of sumoylation suggested a novel regulatory mechanism for the regulation of immune responsive gene expression. In this review, we first update recent advances in the field of sumoylation, then specifically evaluate its regulatory role in several key signaling pathways for immune response and discuss its possible implication in T1D pathogenesis.

Original languageEnglish (US)
Pages (from-to)504-513
Number of pages10
JournalJournal of Molecular Medicine
Volume83
Issue number7
DOIs
StatePublished - Jul 1 2005

Fingerprint

Wrestling
Sumoylation
Ubiquitin
Type 1 Diabetes Mellitus
Ubiquitins
Biological Phenomena
Ubiquitination
Huntington Disease
Post Translational Protein Processing
Acetylation
Methylation
Alzheimer Disease
Phosphorylation
Gene Expression
Proteins

Keywords

  • Autoimmunity
  • Immune
  • Regulation
  • SUMO
  • Sumoylation
  • Transcription

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery
  • Genetics(clinical)

Cite this

Li, M., Guo, D., Isales, C. M., Eizirik, D. L., Atkinson, M., She, J-X., & Wang, C. Y. (2005). SUMO wrestling with type 1 diabetes. Journal of Molecular Medicine, 83(7), 504-513. https://doi.org/10.1007/s00109-005-0645-5

SUMO wrestling with type 1 diabetes. / Li, Manyu; Guo, Dehuang; Isales, Carlos M; Eizirik, Decio L.; Atkinson, Mark; She, Jin-Xiong; Wang, Cong Yi.

In: Journal of Molecular Medicine, Vol. 83, No. 7, 01.07.2005, p. 504-513.

Research output: Contribution to journalReview article

Li, M, Guo, D, Isales, CM, Eizirik, DL, Atkinson, M, She, J-X & Wang, CY 2005, 'SUMO wrestling with type 1 diabetes', Journal of Molecular Medicine, vol. 83, no. 7, pp. 504-513. https://doi.org/10.1007/s00109-005-0645-5
Li, Manyu ; Guo, Dehuang ; Isales, Carlos M ; Eizirik, Decio L. ; Atkinson, Mark ; She, Jin-Xiong ; Wang, Cong Yi. / SUMO wrestling with type 1 diabetes. In: Journal of Molecular Medicine. 2005 ; Vol. 83, No. 7. pp. 504-513.
@article{308b97a02ff0402fa96c6f89a2bf79c4,
title = "SUMO wrestling with type 1 diabetes",
abstract = "Post-translational modification of proteins by phosphorylation, methylation, acetylation, or ubiquitylation represent central mechanisms through which various biological processes are regulated. Reversible covalent modification (i.e., sumoylation) of proteins by the small ubiquitin-like modifier (SUMO) has also emerged as an important mechanism contributing to the dynamic regulation of protein function. Sumoylation has been linked to the pathogenesis of a variety of disorders including Alzheimer's disease (AD), Huntington's disease (HD), and type 1 diabetes (T1D). Advances in our understanding of the role of sumoylation suggested a novel regulatory mechanism for the regulation of immune responsive gene expression. In this review, we first update recent advances in the field of sumoylation, then specifically evaluate its regulatory role in several key signaling pathways for immune response and discuss its possible implication in T1D pathogenesis.",
keywords = "Autoimmunity, Immune, Regulation, SUMO, Sumoylation, Transcription",
author = "Manyu Li and Dehuang Guo and Isales, {Carlos M} and Eizirik, {Decio L.} and Mark Atkinson and Jin-Xiong She and Wang, {Cong Yi}",
year = "2005",
month = "7",
day = "1",
doi = "10.1007/s00109-005-0645-5",
language = "English (US)",
volume = "83",
pages = "504--513",
journal = "Journal of Molecular Medicine",
issn = "0946-2716",
publisher = "Springer Verlag",
number = "7",

}

TY - JOUR

T1 - SUMO wrestling with type 1 diabetes

AU - Li, Manyu

AU - Guo, Dehuang

AU - Isales, Carlos M

AU - Eizirik, Decio L.

AU - Atkinson, Mark

AU - She, Jin-Xiong

AU - Wang, Cong Yi

PY - 2005/7/1

Y1 - 2005/7/1

N2 - Post-translational modification of proteins by phosphorylation, methylation, acetylation, or ubiquitylation represent central mechanisms through which various biological processes are regulated. Reversible covalent modification (i.e., sumoylation) of proteins by the small ubiquitin-like modifier (SUMO) has also emerged as an important mechanism contributing to the dynamic regulation of protein function. Sumoylation has been linked to the pathogenesis of a variety of disorders including Alzheimer's disease (AD), Huntington's disease (HD), and type 1 diabetes (T1D). Advances in our understanding of the role of sumoylation suggested a novel regulatory mechanism for the regulation of immune responsive gene expression. In this review, we first update recent advances in the field of sumoylation, then specifically evaluate its regulatory role in several key signaling pathways for immune response and discuss its possible implication in T1D pathogenesis.

AB - Post-translational modification of proteins by phosphorylation, methylation, acetylation, or ubiquitylation represent central mechanisms through which various biological processes are regulated. Reversible covalent modification (i.e., sumoylation) of proteins by the small ubiquitin-like modifier (SUMO) has also emerged as an important mechanism contributing to the dynamic regulation of protein function. Sumoylation has been linked to the pathogenesis of a variety of disorders including Alzheimer's disease (AD), Huntington's disease (HD), and type 1 diabetes (T1D). Advances in our understanding of the role of sumoylation suggested a novel regulatory mechanism for the regulation of immune responsive gene expression. In this review, we first update recent advances in the field of sumoylation, then specifically evaluate its regulatory role in several key signaling pathways for immune response and discuss its possible implication in T1D pathogenesis.

KW - Autoimmunity

KW - Immune

KW - Regulation

KW - SUMO

KW - Sumoylation

KW - Transcription

UR - http://www.scopus.com/inward/record.url?scp=23744460490&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23744460490&partnerID=8YFLogxK

U2 - 10.1007/s00109-005-0645-5

DO - 10.1007/s00109-005-0645-5

M3 - Review article

VL - 83

SP - 504

EP - 513

JO - Journal of Molecular Medicine

JF - Journal of Molecular Medicine

SN - 0946-2716

IS - 7

ER -